Matthew Paterson, Chief Strategy Officer, contributes to Pharm Tech's, Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience.
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
When asked about the impacts of geopolitical trends, Matthew observed that biotech and pharma clients are "optimizing and diversifying their geographic footprint" to mitigate the effects of political instability. Many organizations are adopting a multi-region strategy, qualifying facilities in both the United States and the United Kingdom to ensure continuity of supply for life-altering medicines.
Read the full article on Pharm Tech's website here.